Details
Stereochemistry | RACEMIC |
Molecular Formula | C20H23NO |
Molecular Weight | 293.4027 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNCC(O)CC12CCC(C3=CC=CC=C13)C4=CC=CC=C24
InChI
InChIKey=FDXQKWSTUZCCTM-UHFFFAOYSA-N
InChI=1S/C20H23NO/c1-21-13-14(22)12-20-11-10-15(16-6-2-4-8-18(16)20)17-7-3-5-9-19(17)20/h2-9,14-15,21-22H,10-13H2,1H3
Molecular Formula | C20H23NO |
Molecular Weight | 293.4027 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
(+)-Oxaprotiline but not (-)-oxaprotiline given chronically potentiates the aggressive behaviour induced by clonidine. | 1983 Mar |
|
Oxaprotiline enantiomers given repeatedly and brain alpha-adrenoceptors. | 1990 |
|
Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls. | 1993 Jun |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:38:42 GMT 2023
by
admin
on
Fri Dec 15 18:38:42 GMT 2023
|
Record UNII |
3V3Z2HK4LS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB09307
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
100000083012
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111067
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
3V3Z2HK4LS
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
5021
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
38207
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
Oxaprotiline
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
C027299
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
C166702
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
DTXSID40866561
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
SUB09501MIG
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY | |||
|
56433-44-4
Created by
admin on Fri Dec 15 18:38:42 GMT 2023 , Edited by admin on Fri Dec 15 18:38:42 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |